EBV+ lymphoproliferative disease following prolonged chemotherapy for refractory LCH. [electronic resource]
Producer: 20080212Description: 728-30 p. digitalISSN:- 1545-5017
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Asparaginase -- administration & dosage
- Cytarabine -- administration & dosage
- Doxorubicin -- administration & dosage
- Drug Therapy, Combination
- Epstein-Barr Virus Infections -- complications
- Fatal Outcome
- Female
- Herpesvirus 4, Human -- physiology
- Histiocytosis, Langerhans-Cell -- complications
- Humans
- Immunocompromised Host
- Infant
- Lymphoma, Large B-Cell, Diffuse -- drug therapy
- Mercaptopurine -- administration & dosage
- Methotrexate -- administration & dosage
- Mycoses -- etiology
- Prednisone -- administration & dosage
- Recurrence
- Rituximab
- Vinblastine -- administration & dosage
- Vincristine -- administration & dosage
- Virus Activation
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.